MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares shot up 7.1% during trading on Tuesday . The company traded as high as C$0.08 and last traded at C$0.08. 123,212 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 362,070 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company’s fifty day simple moving average is C$0.07 and its two-hundred day simple moving average is C$0.07. The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The stock has a market capitalization of C$33.20 million, a P/E ratio of -2.76 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Further Reading
- Five stocks we like better than MediPharm Labs
- What Are Trending Stocks? Trending Stocks Explained
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Manufacturing Stocks Investing
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- P/E Ratio Calculation: How to Assess Stocks
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
